FimmCyte
PrivateLast Round
Convertible Debt
Feb 29, 2024
Total Funding Raised
$2.69M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
FimmCyte is a biotechnology company developing targeted immunotherapies for chronic fibro-inflammatory diseases with an initial focus on endometriosis.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FimmCyte Comparables
Compare FimmCyte with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oriva Therapeutics | 86% | |
| EndoCyclic Therapeutics | 84% | |
| Sur180 Therapeutics | 83% |
FimmCyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Feb 29, 2024 | ||||
| Convertible Debt | Sep 5, 2023 | ||||
| Grant | Jul 13, 2022 |
FimmCyte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Venture Kick | Grant |
| BioInnovation Institute | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 13, 2026
Open roles increased from 0 to 2, representing 29% of headcount.
- Mar 25, 2025
Monthly visitors grew 254% MoM, reaching 1.4K.
FimmCyte Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about FimmCyte's valuation, stock price, and market status.
Is FimmCyte a public or private company?
FimmCyte is a private company.
What is the current stock price of FimmCyte?
FimmCyte is a private company with no public stock price. No recent secondary market data is available.
How much is FimmCyte worth (valuation)?
Valuation information for FimmCyte is not publicly available.
Can I buy FimmCyte stock?
FimmCyte shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was FimmCyte's last funding round?
Funding round information for FimmCyte is not publicly available.
Who are the main investors in FimmCyte?
Investor information for FimmCyte is not publicly disclosed.
Will FimmCyte IPO soon?
No public IPO plans have been announced for FimmCyte.
How can I track FimmCyte secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor FimmCyte's secondary market activity and sign up for updates.